{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:24:47Z","timestamp":1781105087287,"version":"3.54.1"},"reference-count":51,"publisher":"Tech Science Press","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OR"],"published-print":{"date-parts":[[2024]]},"DOI":"10.32604\/or.2024.043423","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T06:43:01Z","timestamp":1714027381000},"page":"1359-1368","source":"Crossref","is-referenced-by-count":8,"title":["Analysis of the role of dihydromyricetin derived from vine tea (<i>Ampelopsis grossedentata<\/i>) on multiple myeloma by activating STAT1\/RIG-I axis"],"prefix":"10.32604","volume":"32","author":[{"given":"WEI","family":"JIANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MEI","family":"ZHOU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17807","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref1","first-page":"1685","article-title":"Multiple myeloma, version 3.2021, NCCN clinical practice guidelines in oncology","volume":"18","author":"Kumar","year":"2020","journal-title":"Multiple Myeloma"},{"key":"ref2","first-page":"3","article-title":"Epidemiology, staging, and management of multiple myeloma","volume":"9","author":"Padala","year":"2021","journal-title":"Medical Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1159\/000520312","article-title":"Multiple myeloma: Molecular pathogenesis and disease evolution","volume":"44","author":"Heider","year":"2021","journal-title":"Oncology Research and Treatment"},{"key":"ref4","first-page":"e17779","article-title":"Cutaneous multiple myeloma","volume":"13","author":"Miriyala","year":"2021","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13045-021-01162-7","article-title":"Prognostic and predictive biomarker developments in multiple myeloma","volume":"14","author":"Wallington-Beddoe","year":"2021","journal-title":"Journal of Hematology & Oncology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.clml.2019.09.623","article-title":"Daratumumab, bortezomib, and dexamethasone versus bortezomib and dexamethasone in patients with previously treated multiple myeloma: Three-year follow-up of CASTOR","volume":"20","author":"Mateos","year":"2020","journal-title":"Clinical Lymphoma Myeloma & Leukemia"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/bjh.17541","article-title":"Carfilzomib, dexamethasone and daratumumab in relapsed or refractory multiple myeloma: Results of the phase III study CANDOR by prior lines of therapy","volume":"194","author":"Quach","year":"2021","journal-title":"British Journal of Haematology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1182\/bloodadvances.2020004146","article-title":"Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed\/refractory multiple myeloma","volume":"5","author":"Costa","year":"2021","journal-title":"Blood Advances"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"6692579","DOI":"10.1155\/2021\/6692579","article-title":"Dihydromyricetin acts as a potential redox balance mediator in cancer chemoprevention","volume":"2021","author":"Chen","year":"2021","journal-title":"Mediators of Inflammation"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"172888","DOI":"10.1016\/j.ejphar.2019.172888","article-title":"Multitarget and promising role of dihydromyricetin in the treatment of metabolic diseases","volume":"870","author":"Tong","year":"2020","journal-title":"European Journal of Pharmacology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3389\/fphar.2018.01204","article-title":"Recent update on the pharmacological effects and mechanisms of dihydromyricetin","volume":"9","author":"Zhang","year":"2018","journal-title":"Frontiers in Pharmacology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"111927","DOI":"10.1016\/j.biopha.2021.111927","article-title":"Molecular mechanisms and therapeutic implications of dihydromyricetin in liver disease","volume":"142","author":"Chen","year":"2021","journal-title":"Biomedicine and Pharmacotherapy"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12640-022-00631-2","article-title":"Dihydromyricetin protects against salsolinol-induced toxicity in dopaminergic cell line: Implication for parkinson\u2019s disease","volume":"41","author":"Getachew","year":"2023","journal-title":"Neurotoxicity Research"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.toxrep.2022.07.013","article-title":"Ampelopsin targets in cellular processes of cancer: Recent trends and advances","volume":"9","author":"Tuli","year":"2022","journal-title":"Toxicology Reports"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"9758","DOI":"10.3892\/mmr.2017.7802","article-title":"Inhibition of human lung cancer proliferation through targeting stromal fibroblasts by dihydromyricetin","volume":"16","author":"Fan","year":"2017","journal-title":"Molecular Medicine Reports"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.intimp.2018.12.025","article-title":"Semaphoring 4D is required for the induction of antioxidant stress and anti-inflammatory effects of dihydromyricetin in colon cancer","volume":"67","author":"Liang","year":"2019","journal-title":"International Immunopharmacology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e0225450","DOI":"10.1371\/journal.pone.0225450","article-title":"Golgi reassembly and stacking protein 65 downregulation is required for the anti-cancer effect of dihydromyricetin on human ovarian cancer cells","volume":"14","author":"Wang","year":"2019","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2478\/acph-2023-0005","volume":"73","author":"Meng","year":"2023","journal-title":"Acta Pharmaceutica"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.7150\/jca.61311","article-title":"Dihydromyricetin inhibits tumor growth and epithelial-mesenchymal transition through regulating miR-455-3p in cholangiocarcinoma","volume":"12","author":"Li","year":"2021","journal-title":"Journal of Cancer"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.7150\/jca.45970","article-title":"Dihydromyricetin inhibits cell proliferation, migration, invasion and promotes apoptosis via regulating miR-21 in human cholangiocarcinoma cells","volume":"11","author":"Chen","year":"2020","journal-title":"Journal of Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"10082","DOI":"10.3748\/wjg.v20.i29.10082","article-title":"Dihydromyricetin inhibits migration and invasion of hepatoma cells through regulation of MMP-9 expression","volume":"20","author":"Zhang","year":"2014","journal-title":"World Journal of Gastroenterology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/19336918.2015.1016686","article-title":"A new role for the PI3K\/Akt signaling pathway in the epithelial-mesenchymal transition","volume":"9","author":"Xu","year":"2015","journal-title":"Cell Adhesion & Migration"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"108984","DOI":"10.1016\/j.abb.2021.108984","article-title":"Molecular mechanism involved in epithelial to mesenchymal transition","volume":"710","author":"Jayachandran","year":"2021","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"ref24","first-page":"2890","article-title":"AGO1 enhances the proliferation and invasion of cholangiocarcinoma via the EMT-associated TGF-\u03b2 signaling pathway","volume":"12","author":"Wu","year":"2020","journal-title":"American Journal of Translational Research"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e358","DOI":"10.1016\/S1470-2045(21)00343-0","article-title":"Novel therapeutic strategies: Targeting epithelial-mesenchymal transition in colorectal cancer","volume":"22","author":"Zhang","year":"2021","journal-title":"Lancet Oncology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.14715\/cmb\/2019.65.7.4","article-title":"Regulation of signaling pathways by Ampelopsin (Dihydromyricetin) in different cancers: Exploring the highways and byways less travelled","volume":"65","author":"Fayyaz","year":"2019","journal-title":"Cellular and Molecular Biology"},{"key":"ref27","first-page":"428","article-title":"Effects of dihydromyricetin on the migration and invasion of human gastric cancer MKN45 cells and its mechanism","volume":"35","author":"Wang","year":"2019","journal-title":"Zhongguo Ying Yong Sheng Li Xue Za Zhi"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3390\/ph14080794","article-title":"Ampelopsin suppresses stem cell properties accompanied by attenuation of oxidative phosphorylation in chemo- and radio-resistant MDA-MB-231 breast cancer cells","volume":"14","author":"Truong","year":"2021","journal-title":"Pharmaceuticals"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s13238-017-0431-5","article-title":"RIG-I: A multifunctional protein beyond a pattern recognition receptor","volume":"9","author":"Xu","year":"2018","journal-title":"Protein & Cell"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1158\/0008-5472.CAN-18-0730","article-title":"Therapeutically active RIG-I agonist induces immunogenic tumor cell killing in breast cancers","volume":"78","author":"Elion","year":"2018","journal-title":"Cancer Research"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1002\/cam4.2501","article-title":"RIG-I promotes IFN\/JAK2 expression and the endoplasmic reticulum stress response to inhibit chemoradiation resistance in nasopharyngeal carcinoma","volume":"8","author":"Jing","year":"2019","journal-title":"Cancer Medicine"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1080\/15384047.2020.1831373","article-title":"LRRC75A-AS1 targets miR-199b-5p\/PDCD4 axis to repress multiple myeloma","volume":"21","author":"Pang","year":"2020","journal-title":"Cancer Biology & Therapy"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.omto.2020.10.004","article-title":"Methylation of the promoter region of the tight junction protein-1 by DNMT1 induces EMT-like features in multiple myeloma","volume":"19","author":"Li","year":"2020","journal-title":"Molecular Therapy-Oncolytics"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1158\/1078-0432.CCR-20-4459","article-title":"Tumor immune microenvironment during epithelial-mesenchymal transition","volume":"27","author":"Taki","year":"2021","journal-title":"Clinical Cancer Research"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","article-title":"EMT transition states during tumor progression and metastasis","volume":"29","author":"Pastushenko","year":"2019","journal-title":"Trends in Cell Biology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00204-021-02983-8","article-title":"Combustion-derived particles from biomass sources differently promote epithelial-to-mesenchymal transition on A549 cells","volume":"95","author":"Marchetti","year":"2021","journal-title":"Archives of Toxicology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.3389\/fimmu.2020.02189","article-title":"STAT1 isoforms differentially regulate NK Cell maturation and anti-tumor activity","volume":"11","author":"Meissl","year":"2020","journal-title":"Frontiers in Immunology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1172\/JCI129205","article-title":"Immunotherapy of multiple myeloma","volume":"130","author":"Minnie","year":"2020","journal-title":"Journal of Clinical Investigation"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"609705","DOI":"10.3389\/fimmu.2020.609705","article-title":"Research status and molecular mechanism of the traditional chinese medicine and antitumor therapy combined strategy based on tumor microenvironment","volume":"11","author":"Zhang","year":"2020","journal-title":"Frontiers in Immunology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2147\/DDDT.S223646","article-title":"Effect and molecular mechanisms of traditional chinese medicine on tumor targeting tumor-associated macrophages","volume":"14","author":"He","year":"2020","journal-title":"Drug Design Development and Therapy"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"153642","DOI":"10.1016\/j.phymed.2021.153642","article-title":"Dihydromyricetin suppresses cell metastasis in human osteosarcoma through SP-1- and NF-\u03baB-modulated urokinase plasminogen activator inhibition","volume":"90","author":"Chou","year":"2021","journal-title":"Phytomedicine"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/OTT.S414032","article-title":"CXCL8 promotes glioma progression by activating the JAK\/STAT1\/HIF-1\u03b1\/Snail signaling axis [Retraction]","volume":"16","author":"Chen","year":"2023","journal-title":"OncoTargets and Therapy"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1002\/jcp.25797","article-title":"Epithelial-mesenchymal transition (EMT): A biological process in the development, stem cell differentiation, and tumorigenesis","volume":"232","author":"Chen","year":"2017","journal-title":"Journal of Cellular Physiology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","article-title":"New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer","volume":"20","author":"Dongre","year":"2019","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"ref45","first-page":"326","article-title":"Dihydromyricetin mediates epithelial mesenchymal transformation and regulates the proliferation and apoptosis of esophageal squamous cell carcinoma cells","volume":"44","author":"Tian","year":"2022","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/s41598-020-58211-3","article-title":"The mechanism of how CD95\/Fas activates the Type I IFN\/STAT1 axis, driving cancer stemness in breast cancer","volume":"10","author":"Qadir","year":"2020","journal-title":"Scientific Reports"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1158\/0008-5472.CAN-19-2306","article-title":"Hypoxia induces transcriptional and translational downregulation of the Type I IFN pathway in multiple cancer cell types","volume":"80","author":"Miar","year":"2020","journal-title":"Cancer Research"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"9957","DOI":"10.2147\/OTT.S257951","article-title":"miR-525-5p modulates proliferation and epithelial-mesenchymal transition of glioma by targeting stat-1","volume":"13","author":"Xie","year":"2020","journal-title":"OncoTargets and Therapy"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1158\/1541-7786.MCR-20-0948","article-title":"An IFN\u03b3\/STAT1\/JMJD3 axis induces ZEB1 expression and promotes aggressiveness in lung adenocarcinoma","volume":"19","author":"Yang","year":"2021","journal-title":"Molecular Cancer Research"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1534735421991217","DOI":"10.1177\/1534735421991217","article-title":"Dihydromyricetin exhibits antitumor activity in nasopharyngeal cancer cell through antagonizing Wnt\/\u03b2-catenin signaling","volume":"20","author":"Ye","year":"2021","journal-title":"Integrative Cancer Therapies"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12906-021-03356-5","volume":"21","author":"Jiang","year":"2021","journal-title":"BMC Complementary Medicine and Therapies"}],"container-title":["Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.techscience.com\/files\/or\/2024\/TSP_OR-32-8\/OncolRes-32-08-43423\/OncolRes-32-43423.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T11:17:52Z","timestamp":1741259872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v32n8\/57309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":51,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024]]},"published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.32604\/or.2024.043423","relation":{},"ISSN":["1555-3906"],"issn-type":[{"value":"1555-3906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}